About us

Board & Working Parties

EFPIA Governance

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

EFPIA Board

The Board sets EFPIA's strategy priorities, key objectives, and approval of EFPIA policy positions, thereby ensuring good governance and public policy alignment for EFPIA in a global context.

Board members (2015 - 2017) 

President: Joseph Jimenez, Novartis (from 29 October 2014)

Vice President: Dr. Stefan Oschmann, Merck (from 9 December 2014)

Second Vice-President: Marc de Garidel, Ipsen (from 9 December 2014)

  • Gitte AABO (LEO Pharma)
  • Carlos ALBAN (AbbVie)
  • Lucia ALEOTTI (Menarini)
  • Alberto CHIESI (Chiesi)
  • Ruud DOBBER (AstraZeneca)
  • Joaquin DUATO (J&J)
  • Antoni ESTEVE (Esteve)
  • Jacqualyn FOUSE (Celgene)
  • Jorge GALLARDO (Almirall)
  • Murdo GORDON (BMS)
  • Peter GUENTER (Sanofi)
  • Allan HILLGROVE (Boehringer Ingelheim)
  • Anthony HOOPER (Amgen)
  • Abbas HUSSAIN (GSK)
  • Carlo INCERTI (Genzyme)
  • Olivier LAUREAU (Servier)
  • Daniel O’DAY (Roche)
  • Eric-Paul PAQUES (Grünenthal)
  • David RICKS (Eli Lilly)
  • Jakob RIIS (NovoNordisk)
  • Adam SCHECHTER (MSD)
  • Kåre SCHULTZ (Lundbeck)
  • Jean-Christophe TELLIER (UCB)
  • Michel VOUNATSOS (Biogen)
  • Dieter WEINAND (Bayer)
  • John YOUNG (Pfizer)
  • Gianni ZAMPIERI (Vifor Pharma)

Ex Officio Member Delegates

  • Thomas CUENI (scienceindustries)

  • Enrica GIORGETTI (Farmindustria)

General Management:

  • Eric Cornut (EFPIA Interim Director General)
  • Marie-Claire PICKAERT (EFPIA Deputy Director General)

EFPIA European Markets Committee

Chair: Andrew HOTCHKISS - Eli Lilly

Vice-Chair: Erik J. VAN SNIPPENBERG - GSK

  Thomas CUENI - CH

Corporate Delegates: 

  • Satu AHOMAKI - Orion
  • Richard BLACKBURN - Pfizer
  • Nick BURGIN - Eisai
  • Alessandro CHIESI- Chiesi
  • Sören Bo CHRISTIANSEN - Merck & Co (MSD)
  • Guillaume CLEMENT - Leo Pharma
  • Willy CNOPS- UCB
  • Luc DIRCKX - Roche
  • Mark FLADRICH - AstraZeneca
  • Reinhard FRANZEN - Bayer
  • Johanna FRIEDL-NADERER - Biogen
  • Jane GRIFFITHS  - J&J
  • Alberto GRUA - Grunenthal
  • Jerzy GRUHN - Novo Nordisk
  • Guido GUIDI - Novartis
  • Tim KNEEN - Merck Serono
  • Corinne Le GOFF - Amgen
  • Marc-Antoine LUCCHINI - Sanofi
  • Peter MEEUS - Baxalta
  • Pio MEI - Menarini
  • Johanna MERCIER - BMS
  • Gianfranco NAZZI - Teva
  • João Carlos NUNES ROCHA - Lundbeck
  • Tuomo PATSI - Celgene
  • Esteban PLATA - AbbVie
  • Marc PRINCEN - Takeda
  • Hugues RENAUT - Servier
  • Albert ROS-MORTE - Boehringer Ing.
  • Kim STRATTON - Shire
  • Ole VAHLGREN - Otsuka
  • Pascal WAUCQUEZ - Ipsen

Member Associations Delegates: 

  • Humberto ARNES - ES
  • Karita BEKKEMELLEN - NO
  • Anders BLANCK - SW
  • Heitor COSTA - PT
  • Umit DERELI - TR
  • Birgit FISCHER - VFA
  • Enrica GIORGETTI - IT
  • Mihalis HIMONAS - GR
  • Jan HUBER - NL
  • Ida Sofie JENSEN - DK
  • Philippe LAMOUREUX  - FR
  • Franz LATZKO  - AT
  • Jussi MERIKALLIO  - FI
  • Oliver O'CONNOR - IE
  • Carine RUTTEN - BE
  • Gerard SCHOUW - NL
  • Vladimir SHIPKOV - RS
  • Pawel SZTWIERTNIA  - PL
  • Mike THOMPSON - UK

General Management:

  • Eric Cornut (EFPIA Interim Director General)
  • Marie-Claire PICKAERT (EFPIA Deputy Director General)
  • François BOUVY (EFPIA Director Market Access)

PhRMA Guest

  • Jonathan KIMBALL

EFPIA Board Sponsored Committees

Board Sponsored Commmittees may set up Committees or working groups (WGs) in order to tackle specific issues or areas.

There are four EFPIA Board Sponsored Committees:

  • "Finance and Operations" mandates: Chair - Stefan OSCHMANN, Merck
  • "International" mandates:  Chair - David RICKS, Eli Lilly
  • "Patient Access" mandates: Chair - Adam SCHECHTER, MSD
  • "Innovation" mandates: Chair - Jean-Christophe TELLIER, UCB